Tenet Healthcare Corp (THC)
- Sector
- Health Care
- Last price
- $271.60
- As of
Kresmion compiles this page from THC's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
TENET HEALTHCARE CORP (THC): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-22.
See the full THC dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for THC on one page. Preview it with sample data, then open it live with a free account.
Preview the THC dossierActive signals for THC
- highCONSENSUS_SELL
3 tracked funds reduced THC this 2026Q2, institutional consensus
- highCONSENSUS_BUY
6 tracked funds increased THC this 2026Q2, institutional consensus
- highinsider_cluster_sell
2 insiders at THC sold $28.0M this week
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +962% to THC (2026Q2)
- highCONSENSUS_SELL
4 tracked funds reduced THC this 2026Q2, institutional consensus
FREE, NO ACCOUNT
Every signal on THC, as it fires
You are seeing 5 of 25 signals recorded on THC since 2026-05-31.
The five above landed across 3 days. The other 20 were recorded on 3 other days. 16 of the 25 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in THC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 88033G407 · 2026Q2 | $330.3M | 0.04% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 88033G407 · 2026Q2 | $86.3M | 0.03% | , |
| Point72 Asset Management, L.P.CUSIP 88033G407 · 2026Q2 | $35M | 0.04% | , |
| Bridgewater Associates, LPCUSIP 88033G407 · 2026Q2 | $7.9M | 0.03% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 88033G407 · 2026Q2 | $7.4M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 88033G407 · 2026Q2 | $5.7M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, THC
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
THC against its peers
THC's operating margin of 16.5% ranks in the 77th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | THC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 21.3B USD | 1.9B USD | 90 | 25 |
| Gross margin | n/a | 59.0% | n/a | 17 |
| Operating margin | 16.5% | 8.5% | 77 | 23 |
| Net margin | 11.1% | 5.5% | 79 | 25 |
| Return on equity | 56.1% | 11.9% | 98 | 24 |
| P / E | 17.5x | 37.6x | 3 | 17 |
| 1 year | 38.3% | 13.2% | 67 | 22 |
Peers (25): GH, MDLN, BTSG, PEN, EHC, MOH, ENSG, GKOS, MASI, VEEV, HNGE, HIMS, PACS, LNTH, CHE, RDNT, DOCS, HAE, TFX, MMSI, WAY, OPCH, ITGR, LIVN, CRVL. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (THC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow THC on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to THC for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.